BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25172603)

  • 1. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.
    Rudzianskas V; Inciura A; Juozaityte E; Rudzianskiene M; Kubilius R; Vaitkus S; Kaseta M; Adliene D
    Acta Otorhinolaryngol Ital; 2012 Oct; 32(5):297-303. PubMed ID: 23326008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
    Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
    Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
    Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Chin RK; Park SJ; Kamrava M
    Head Neck; 2018 Jul; 40(7):1524-1533. PubMed ID: 29573121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
    Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review.
    Tagliaferri L; Bussu F; Fionda B; Catucci F; Rigante M; Gambacorta MA; Autorino R; Mattiucci GC; Miccichè F; Placidi E; Balducci M; Galli J; Paludetti G; Kovacs G; Valentini V
    Tumori; 2017 Nov; 103(6):516-524. PubMed ID: 28291904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?
    Bartochowska A; Skowronek J; Wierzbicka M; Leszczynska M; Szyfter W
    Brachytherapy; 2015; 14(6):933-8. PubMed ID: 26249122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.
    Wierzbicka M; Bartochowska A; Strnad V; Strojan P; Mendenhall WM; Harrison LB; Rinaldo A; Sahai P; Wiegand S; Ferlito A
    Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):269-76. PubMed ID: 25338181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
    Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
    Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
    Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
    Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
    Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.
    Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA
    Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.
    Haddad A; Peiffert D; Lapeyre M; Harter V; Buchheit I; Graff P
    Brachytherapy; 2014; 13(6):597-602. PubMed ID: 24913434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.